Track the Orexo AB stock price and the full insider trade history of the company, a listed equity based in Finland. Shares trade on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Orexo AB has recorded 6 insider filings. Market capitalisation: €546.6m. The latest transaction was filed on 4 September 2025 (Purchase). Among the most active insiders: Nikolaj Arrild Sørensen. The full history is free.
6
Insider Decl.
n/a
Thresholds
€49,224
6 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Orexo AB Strong Buy (bullish), based on 1 analysts. Average price target: SEK 26.50.
31Σ signal
Buys €49,224n/a Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,460 shares@ €1.29150.0005% mcap100.0% of flowAktieISINISIN SE0000736415FI:A003N442-1
6 of 6 declarations
About Orexo AB
Orexo AB is a Swedish pharmaceutical company focused on developing treatments for addiction and pain disorders. It is listed on the Stockholm Stock Exchange (XSTO).